Tubal ligation and fatal ovarian cancer in a large prospective cohort study

American Journal of Epidemiology

Volumn 145, Issue 4, 1997, Pages 349-357

  Miracle McMahill, Heidi L ^a   Calle, Eugenia E ^a   Kosinski, Andrzej S ^b   Rodriguez, Carmen ^a   Wingo, Phyllis A ^a   Thun, Michael J ^a   Heath Jr , Clark W ^a  

^a AMERICAN CANCER SOCIETY   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

cohort studies; ovarian neoplasms; sterilization; tubal

Indexed keywords

ARTICLE; CANCER MORTALITY; CANCER RISK; FEMALE; FEMALE STERILIZATION; HUMAN; HYSTERECTOMY; OVARY CANCER; PROGNOSIS; RISK ASSESSMENT; UTERINE TUBE LIGATION;

EID: 0031042916     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a009112     Document Type: Article

References (59)

1. Parker SL, Tong T, Bolden S, et al. Cancer statistics 1996. CA Cancer J Clin 1996;46:5-27.
2. Kosary CL, Ries LAS, Miller BA, et al, eds. SEER cancer statistics review, 1973-1992: tables and graphs. Bethesda, MD: National Cancer Institute, 1995. (NIH publication no. 95-2789).
3. Harlow BL, Weiss NL, Roth GJ, et al. Case-control study of borderline ovarian cancer tumors: reproductive, history and exposure to exogenous female hormones. Cancer Res 1988;48:5849-52.
4. Booth M, Beral V, Smith P. Risk factors for ovarian cancer: a case-control study. Br J Cancer 1989;66:592-8.
5. Whittemore AS, Harris R, Itnyre J, et al. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Am J Epidemiol 1992;136:1184-203.
6. Tavani A, Negri E, Franchesci S, et al. Risk factors for epithelial ovarian cancer in women under age 45. Eur J Cancer 1993;29A:1297-301.
7. Lee NC, Wingo PA, Gwinn ML, et al. The reduction in risk of ovarian cancer associated with oral contraceptive use. N Engl J Med 1987;11:650-5.
8. Gwinn ML, Lee NC, Rhodes PH, et al. Pregnancy, breast feeding and oral contraceptives and the risk of epithelial ovarian cancer. J Clin Epidemiol 1990;43:559-68.
9. Wu ML, Whittemore AS, Paffenbarger RS Jr, et al. Personal and environmental characteristics related to epithelial ovarian cancer, I. Reproductive and menstrual events and oral contraceptive use. Am J Epidemiol 1988;128:1216-27.
10. Nasca PC, Greenwald P, Chorost S, et al. An epidemiologic case-control study of ovarian cancer and reproductive factors. Am J Epidemiol 1984;119:705-13.
11. Byers T, Marshall J, Graham S, et al. A case-control study of dietary and nondietary factors in ovarian cancer. J Nail Cancer Inst 1983;71:681-6.
12. Negri E, Franchesci S, Tzonou A, et al. Pooled analysis of 3 European case-control studies, I. Reproductive factors and risk of epithelial ovarian cancer. Int J Cancer 1991;49:50-6.
13. Hildreth NG, Kelsey JL, LiVolsi VA, et al. An epidemiologic study of epithelial carcinoma of the ovary. Am J Epidemiol 1981;114:398-405.
14. Hartge P, Schiffman MH, Hoover R, et al. A case-control study of epithelial ovarian cancer. Am J Obstet Gynecol 1989;161:10-16.
15. Peterson LS. Contraceptive use in the United States: 1982-1990. Hyattsville, MD: National Center for Health Statistics, 1995. (Advance Data from Vital and Health Statistics publication no. 260).
16. Hartge P, Hoover R, McGowan L, et al. Menopause and ovarian cancer. Am J Epidemiol 1988;127:990-8.
17. Mori M, Harabuchi I, Miyake H, et al. Reproductive, genetic, and dietary risk factors for ovarian cancer. Am J Epidemiol 1988;128:771-7.
18. Koch M, Jenkins M, Gaedke H, et al. Risk factors of ovarian cancer of epithelial origin: a case-control study. Cancer Detect Prev 1988;13:131-6.
19. Shu XO, Brinton LA, Gao YT, et al. Population-based case-control study of ovarian cancer in Shanghai. Cancer Res 1989;49:3670-4.
20. Whittemore AS, Wu ML, Paffenbarger RS Jr, et al. Personal and environmental characteristics related to epithelial ovarian cancer: II. Exposures to talcum powder, tobacco, alcohol and coffee. Am J Epidemiol 1988;128:1228-40.
21. Irwin KL, Weiss NS, Lee NC, et al. Tubal sterilization, hysterectomy, and the subsequent occurrence of epithelial ovarian cancer. Am J Epidemiol 1991;134:362-9.
22. Hankinson SE, Hunter DJ, Colditz GA, et al. Tubal ligation, hysterectomy and risk of ovarian cancer: a prospective study. JAMA 1993;270:2813-18.
23. Koch M, Starreveld AA, Hill GB, et al. The effect of tubal ligation on the incidence of epithelial cancer of the ovary. Cancer Detect Prev 1984;7:241-5.
24. McGowan L, Parent L, Lednar W, et al. The woman at risk for developing ovarian cancer. Gynecol Oncol 1979;7:325-44.
25. Calle EE, Terrell DD. Utility of the National Death Index for ascertainment of mortality among Cancer Prevention Study II participants. Am J Epidemiol 1993;137:235-41.
26. World Health Organization. International classification of diseases. Manual of the international statistical classification of disease, injuries, and causes of death. Vol 1, 9th rev. Geneva: WHO, 1977.
27. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
28. Savage IR. Contributions to the theory of rank order statistics - the two sample case. Ann Math Stat 1956;27:590-615.
29. Cox DR. Regression models and life tables (with discussion). J R Stat Assoc 1972;34:187-220.
30. SAS technical report P-229: SAS/STAT software changes and enhancements, release 6.07. Cary, NC: SAS Institute, Inc., 1992.
31. Kleinbaum DG, Kupper LI, Morgenstern H. Epidemiologic research: principles and quantitative methods. New York, NY: Van Nostrand Reinhold, 1982.
32. Cox DR, Oakes D. Analysis of survival data. London: Chapman and Hall, 1984.
33. Breslow NE, Day NE, eds. Statistical methods in cancer research. Vol 2. The design and analysis of cohort studies. Lyon, France: International Agency for Research on Cancer, 1987. (IARC scientific publication no. 82).
34. Breslow NE. Covariance analysis of censored survival data. Biometrics 1974;30:89-99.
35. Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York, NY: John Wiley and Sons, 1980.
36. Little RJA, Rubin DB. The statistical analysis of missing data. New York, NY: John Wiley and Sons, 1987.
37. Kelsey JL, Thompson WD, Evans AS. Methods in observational epidemiology. New York, NY: Oxford University Press, 1986.
38. Fathalla MF. Incessant ovulation - a factor in ovarian neoplasia? Lancet 1971;2:163.
39. Williams EL, Jones ME, Merrill RE. The subsequent course of patients sterilized by tubal ligation. Am J Obstet Gynecol 1951;61:423-6.
40. Neil JR, Noble Ad, Hammond GT, et al. Late complications of sterilization by laparoscopy and tubal ligation. Lancet 1975;2:699-700.
41. Phillips JM, Corson SL, Keith L. Laparoscopy. Baltimore, MD: Williams & Wilkins, 1977:159.
42. Radwanska E, Berger G, Hammond J. Luteal deficiency among women with normal menstrual cycles requesting reversal of tubal sterilization. Obstet Gynecol 1979;54:189.
43. DeStefano F, Perlman JA, Peterson HB, et al. Long-term risk of menstrual disturbances after tubal sterilization. Am J Obstet Gynecol 1985;152:835-41.
44. Sorenson T, Ladehoff P. Late complications of sterilization in women. Ugeskr Laeger 1979;141:998.
45. Lu T, Chun D. A long term follow-up study of 1,055 cases of postpartum tubal ligation. J Obstet Gynaecol Br Commonw 1967;74:875.
46. Alvarez-Sanchez F, Segal SJ, Brache V, et al. Pituitary-ovarian function after tubal ligation. Fertil Steril 1981;36:606-9.
47. Cattanach J. Oestrogen deficiency after tubal ligation. Lancet 1985;1:847-9.
48. Donnez J, Wauters M, Thomas K, et al. Luteal function after tubal sterilization. Obstet Gynecol 1981;57;65-8.
49. Corson SL, Levinson CJ, Batzer FR, et al. Hormonal levels following sterilization and hysterectomy. J Reprod Med 1981;26:363-9.
50. Cramer DW, Welch WR. Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis. J Natl Cancer Inst 1983;71:717-21.
51. Woodruff JD. The pathogenesis of ovarian neoplasia. Johns Hopkins Med J 1979;144:117-20.
52. Cramer DW, Xu H. Epidemiologic evidence for uterine growth factors in the pathogenesis of ovarian cancer. Ann Epidemiol 1995;4:310-14.
53. Irwin KL. Wingo PA, Lee NC. Agreement of self-reported ovarian number following gynecologic surgery with medical record reports. J Clin Epidemiol 1990;43:181-9.
54. Horwitz RI. Comparison of epidemiologic data from multiple sources. J Chron Dis 1986;39:889-96.
55. Brinton LA, Hoover RN, Szklo M, et al. Menopausal estrogen use and risk of breast cancer. Cancer 1981;47:2517-22.
56. Horwitz RI, Yu EC. Problems and proposals for interview data in epidemiological research. Int J Epidemiol 1985;14:463-7.
57. Paganini-Hill A, Ross RK. Reliability of recall of drug usage and other health-related information. Am J Epidemiol 1982;11:114-22.
58. Colditz GA, Stampfer MJ, Willett WC, et al. Reproducibility and validity of self-reported menopausal status in a prospective cohort study. Am J Epidemiol 1987;126:319-25.
59. Hulka JF. Current status of elective sterilization in the United States. Fertil Steril 1977;28:515-20.